If a patient’s genetic test generates results that are actionable, will that patient move forward with treatment? That is one question asked by researchers in a study led by Vanderbilt University Medical Center that was published in the American Journal of Human Genetics. A pool of 16,218 research participants were genotyped. “Genetic counselors at six […]
January 16, 2024, Intelligence: Late-Breaking Lab News
- By Robert Michel
- > From the Volume XXXI, Number 1 - January 16, 2024 Issue
- Tags: American Journal of Human Genetics, arrhythmia, breast cancer, cardiomyopathy, colorectal cancer, Department of Justice, DOJ, Duke University Health System, EarlyDiagnostics, familial hypercholesterolemia, federal antitrust regulator, Federal Trade Commission, FTC, FTC investigator, genetic counselor, genotype, Gregory Critchfield MD, healthcare consolidation, Healthcare Dive, myriad genetics, pathogenic variant, Quest Diagnostics, Saladax Biomedical, Sara Prognostics, University of Pittsburgh Medical Center, UPMC, Vanderbilt University Medical Center, Washington Health System, Yuri Fesko MD
